HCT Guidelines for Referral Timing and Post-Transplant Care
This free two-part guidelines toolkit is available in multiple formats (mobile app, print, and online) and contains:
- Up-to-date HCT Referral Guidelines for autologous and allogeneic transplant consultation timing based on risk for disease progression for more than 20 diseases. Includes updated prognostic factors for AML risk stratification.
- Long-Term Survival Guidelines for recommended post-transplant care—including long-term screening, vaccinations, chronic GVHD screening based on the new NIH consensus development project, and photo atlas. The guidelines help clinicians recognize post-transplant complications early, when therapeutic options are more effective.
*The free mobile app also includes disease-specific outcomes data, clinical research summaries and patient-specific post-transplant guidelines, including long-term screening and a chronic GVHD symptom checker. —The mobile app is available as a free download on Apple® and AndroidTM devices.
Apple, the Apple logo, iPhone, iPod touch, and iTunes are trademarks of Apple Inc., registered in the U.S. and other countries. iPad is a trademark of Apple Inc. App Store is a service mark of Apple Inc.
Android is a trademark of Google Inc. Use of this trademark is subject to Google Permissions.